Home | Welcome to Contract Pharma   
Last Updated Tuesday, January 27 2015

Print

Search Results for 'ACM Global Relocates to Expanded Facilities'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By S. Harachand, Contributing Editor
Published July 21, 2014
As they focus on generic biologics, Indian firms are setting their sights on monoclonal antibodies Read More »
Published May 20, 2014
To expand and upgrade facilities in Switzerland, U.S. and Germany Read More »
Too Much CMO Capacity?
By Eric A. Langer, BioPlan Associates
Published March 7, 2014
A decade ago, there were dire concerns that the biopharmaceutical industry was headed for a severe crisis. There was, it was thought, inadequate mammalian manufacturing capacity to support the development pipeline. In particular, fears grew about sho… Read More »
By Kristin Brooks
Published December 10, 2013
To manufacture injectable suspension product at new facility Read More »
Published November 7, 2013
Adds two high-capacity PSD process trains Read More »
By Gil Roth
Published October 14, 2013
Biologics, ADCs push growth Read More »
Published November 27, 2012
York facility offers 14,500 sq. ft. of lab and office space Read More »
Published January 14, 2015
Validates MSD V-PLEX 10-plex Proinflammatory Panel Read More »
Published December 3, 2014
To encompass pipeline-building, outsourcing alliance, and open innovation initiatives Read More »
Solid Dosage Outsourcing Trends
By Tom Spurgeon, Contract Pharma
Published March 7, 2014
CMOs look for technological, niche advantages Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On